Despite their popularity, GLP-1 agonist receptors carry risks that are often downplayed by Big Pharma, including associations with 19 different health conditions.
There is an increase in osteoporotic fractures the longer one is on these drugs, particularly in post-menopausal women. I have seen it happen in more than one friend.
O/T, thought this might be of interest: https://scitechdaily.com/scientists-discover-a-new-way-to-detect-inflammation-and-it-could-change-medicine/
There is an increase in osteoporotic fractures the longer one is on these drugs, particularly in post-menopausal women. I have seen it happen in more than one friend.